{"id":"https://openalex.org/W2008377983","doi":"https://doi.org/10.1038/bjc.2014.188","title":"In vivo and in vitro properties of STX2484: a novel non-steroidal anti-cancer compound active in taxane-resistant breast cancer","display_name":"In vivo and in vitro properties of STX2484: a novel non-steroidal anti-cancer compound active in taxane-resistant breast cancer","publication_year":2014,"publication_date":"2014-06-24","ids":{"openalex":"https://openalex.org/W2008377983","doi":"https://doi.org/10.1038/bjc.2014.188","mag":"2008377983","pmid":"https://pubmed.ncbi.nlm.nih.gov/24960406","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/4102933"},"language":"en","primary_location":{"id":"doi:10.1038/bjc.2014.188","doi":"https://doi.org/10.1038/bjc.2014.188","is_oa":true,"landing_page_url":"https://doi.org/10.1038/bjc.2014.188","pdf_url":"https://www.nature.com/articles/bjc2014188.pdf","source":{"id":"https://openalex.org/S62966998","display_name":"British Journal of Cancer","issn_l":"0007-0920","issn":["0007-0920","1532-1827"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":"cc-by-nc-sa","license_id":"https://openalex.org/licenses/cc-by-nc-sa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Cancer","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://www.nature.com/articles/bjc2014188.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"C Stengel","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801748203","display_name":"Hammersmith Hospital","ror":"https://ror.org/05jg8yp15","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I153355300","https://openalex.org/I2801748203"]},{"id":"https://openalex.org/I45129253","display_name":"University College London","ror":"https://ror.org/02jx3x895","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I45129253"]},{"id":"https://openalex.org/I47508984","display_name":"Imperial College London","ror":"https://ror.org/041kmwe10","country_code":"GB","type":"education","lineage":["https://openalex.org/I47508984"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"C Stengel","raw_affiliation_strings":["1] Oncology Drug Discovery Group, Section of Investigative Medicine, Hammersmith Hospital, Imperial College London, London W12 0NN, UK [2] Cancer Institute, UCL, 72 Huntley Street, London WC1E 6BT, UK","Oncology Drug Discovery Group, Section of Investigative Medicine, Hammersmith Hospital, Imperial College London, London, W12 0NN, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1] Oncology Drug Discovery Group, Section of Investigative Medicine, Hammersmith Hospital, Imperial College London, London W12 0NN, UK [2] Cancer Institute, UCL, 72 Huntley Street, London WC1E 6BT, UK","institution_ids":["https://openalex.org/I2801748203","https://openalex.org/I45129253","https://openalex.org/I47508984"]},{"raw_affiliation_string":"Oncology Drug Discovery Group, Section of Investigative Medicine, Hammersmith Hospital, Imperial College London, London, W12 0NN, UK","institution_ids":["https://openalex.org/I2801748203","https://openalex.org/I47508984"]}]},{"author_position":"middle","author":{"id":null,"display_name":"S P Newman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801748203","display_name":"Hammersmith Hospital","ror":"https://ror.org/05jg8yp15","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I153355300","https://openalex.org/I2801748203"]},{"id":"https://openalex.org/I47508984","display_name":"Imperial College London","ror":"https://ror.org/041kmwe10","country_code":"GB","type":"education","lineage":["https://openalex.org/I47508984"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"S P Newman","raw_affiliation_strings":["Oncology Drug Discovery Group, Section of Investigative Medicine, Hammersmith Hospital, Imperial College London, London, W12 0NN, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncology Drug Discovery Group, Section of Investigative Medicine, Hammersmith Hospital, Imperial College London, London, W12 0NN, UK","institution_ids":["https://openalex.org/I2801748203","https://openalex.org/I47508984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017572010","display_name":"Joanna M. Day","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801748203","display_name":"Hammersmith Hospital","ror":"https://ror.org/05jg8yp15","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I153355300","https://openalex.org/I2801748203"]},{"id":"https://openalex.org/I47508984","display_name":"Imperial College London","ror":"https://ror.org/041kmwe10","country_code":"GB","type":"education","lineage":["https://openalex.org/I47508984"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"J M Day","raw_affiliation_strings":["Oncology Drug Discovery Group, Section of Investigative Medicine, Hammersmith Hospital, Imperial College London, London, W12 0NN, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncology Drug Discovery Group, Section of Investigative Medicine, Hammersmith Hospital, Imperial College London, London, W12 0NN, UK","institution_ids":["https://openalex.org/I2801748203","https://openalex.org/I47508984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111998855","display_name":"Surinder K. Chander","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801748203","display_name":"Hammersmith Hospital","ror":"https://ror.org/05jg8yp15","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I153355300","https://openalex.org/I2801748203"]},{"id":"https://openalex.org/I47508984","display_name":"Imperial College London","ror":"https://ror.org/041kmwe10","country_code":"GB","type":"education","lineage":["https://openalex.org/I47508984"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"S K Chander","raw_affiliation_strings":["Oncology Drug Discovery Group, Section of Investigative Medicine, Hammersmith Hospital, Imperial College London, London, W12 0NN, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncology Drug Discovery Group, Section of Investigative Medicine, Hammersmith Hospital, Imperial College London, London, W12 0NN, UK","institution_ids":["https://openalex.org/I2801748203","https://openalex.org/I47508984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108600774","display_name":"Fabrice L. Jourdan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I51601045","display_name":"University of Bath","ror":"https://ror.org/002h8g185","country_code":"GB","type":"education","lineage":["https://openalex.org/I51601045"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"F L Jourdan","raw_affiliation_strings":["Medicinal Chemistry, Department of Pharmacy and Pharmacology, University of Bath, Bath BA2 7AY, UK","Department of Pharmacy and Pharmacology, Medicinal Chemistry, University of Bath, Bath, BA2 7AY, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medicinal Chemistry, Department of Pharmacy and Pharmacology, University of Bath, Bath BA2 7AY, UK","institution_ids":["https://openalex.org/I51601045"]},{"raw_affiliation_string":"Department of Pharmacy and Pharmacology, Medicinal Chemistry, University of Bath, Bath, BA2 7AY, UK","institution_ids":["https://openalex.org/I51601045"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112027977","display_name":"Mathew P. Leese","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I51601045","display_name":"University of Bath","ror":"https://ror.org/002h8g185","country_code":"GB","type":"education","lineage":["https://openalex.org/I51601045"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"M P Leese","raw_affiliation_strings":["Medicinal Chemistry, Department of Pharmacy and Pharmacology, University of Bath, Bath BA2 7AY, UK","Department of Pharmacy and Pharmacology, Medicinal Chemistry, University of Bath, Bath, BA2 7AY, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medicinal Chemistry, Department of Pharmacy and Pharmacology, University of Bath, Bath BA2 7AY, UK","institution_ids":["https://openalex.org/I51601045"]},{"raw_affiliation_string":"Department of Pharmacy and Pharmacology, Medicinal Chemistry, University of Bath, Bath, BA2 7AY, UK","institution_ids":["https://openalex.org/I51601045"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056538655","display_name":"Eric Ferrandis","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I183367347","display_name":"Ipsen (France)","ror":"https://ror.org/00d801g55","country_code":"FR","type":"company","lineage":["https://openalex.org/I183367347"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"E Ferrandis","raw_affiliation_strings":["Systems Biology, IPSEN, 5 Avenue du Canada, Les Ulis 91966, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Systems Biology, IPSEN, 5 Avenue du Canada, Les Ulis 91966, France","institution_ids":["https://openalex.org/I183367347"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004174820","display_name":"Sandra Regis-Lydi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I183367347","display_name":"Ipsen (France)","ror":"https://ror.org/00d801g55","country_code":"FR","type":"company","lineage":["https://openalex.org/I183367347"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"S Regis-Lydi","raw_affiliation_strings":["Systems Biology, IPSEN, 5 Avenue du Canada, Les Ulis 91966, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Systems Biology, IPSEN, 5 Avenue du Canada, Les Ulis 91966, France","institution_ids":["https://openalex.org/I183367347"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113898464","display_name":"Barry V. L. Potter","orcid":"https://orcid.org/0000-0003-3255-9135","observed_orcids":["https://orcid.org/0000-0003-3255-9135"]},"institutions":[{"id":"https://openalex.org/I51601045","display_name":"University of Bath","ror":"https://ror.org/002h8g185","country_code":"GB","type":"education","lineage":["https://openalex.org/I51601045"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"B V L Potter","raw_affiliation_strings":["Medicinal Chemistry, Department of Pharmacy and Pharmacology, University of Bath, Bath BA2 7AY, UK","Department of Pharmacy and Pharmacology, Medicinal Chemistry, University of Bath, Bath, BA2 7AY, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medicinal Chemistry, Department of Pharmacy and Pharmacology, University of Bath, Bath BA2 7AY, UK","institution_ids":["https://openalex.org/I51601045"]},{"raw_affiliation_string":"Department of Pharmacy and Pharmacology, Medicinal Chemistry, University of Bath, Bath, BA2 7AY, UK","institution_ids":["https://openalex.org/I51601045"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113603781","display_name":"Michael J. Reed","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801748203","display_name":"Hammersmith Hospital","ror":"https://ror.org/05jg8yp15","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I153355300","https://openalex.org/I2801748203"]},{"id":"https://openalex.org/I47508984","display_name":"Imperial College London","ror":"https://ror.org/041kmwe10","country_code":"GB","type":"education","lineage":["https://openalex.org/I47508984"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"M J Reed","raw_affiliation_strings":["Oncology Drug Discovery Group, Section of Investigative Medicine, Hammersmith Hospital, Imperial College London, London, W12 0NN, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncology Drug Discovery Group, Section of Investigative Medicine, Hammersmith Hospital, Imperial College London, London, W12 0NN, UK","institution_ids":["https://openalex.org/I2801748203","https://openalex.org/I47508984"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109917773","display_name":"Agam Purohit","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801748203","display_name":"Hammersmith Hospital","ror":"https://ror.org/05jg8yp15","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I153355300","https://openalex.org/I2801748203"]},{"id":"https://openalex.org/I47508984","display_name":"Imperial College London","ror":"https://ror.org/041kmwe10","country_code":"GB","type":"education","lineage":["https://openalex.org/I47508984"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"A Purohit","raw_affiliation_strings":["Oncology Drug Discovery Group, Section of Investigative Medicine, Hammersmith Hospital, Imperial College London, London, W12 0NN, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncology Drug Discovery Group, Section of Investigative Medicine, Hammersmith Hospital, Imperial College London, London, W12 0NN, UK","institution_ids":["https://openalex.org/I2801748203","https://openalex.org/I47508984"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5082393921","display_name":"Paul Foster","orcid":"https://orcid.org/0000-0001-7190-1592","observed_orcids":["https://orcid.org/0000-0001-7190-1592"]},"institutions":[{"id":"https://openalex.org/I2801748203","display_name":"Hammersmith Hospital","ror":"https://ror.org/05jg8yp15","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I153355300","https://openalex.org/I2801748203"]},{"id":"https://openalex.org/I47508984","display_name":"Imperial College London","ror":"https://ror.org/041kmwe10","country_code":"GB","type":"education","lineage":["https://openalex.org/I47508984"]},{"id":"https://openalex.org/I79619799","display_name":"University of Birmingham","ror":"https://ror.org/03angcq70","country_code":"GB","type":"education","lineage":["https://openalex.org/I79619799"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"P A Foster","raw_affiliation_strings":["1] Oncology Drug Discovery Group, Section of Investigative Medicine, Hammersmith Hospital, Imperial College London, London W12 0NN, UK [2] Centre for Endocrinology, Diabetes, and Metabolism, School of Clinical and Experimental Medicine, University of Birmingham, Birmingham B15 2TT, UK","Centre for Endocrinology, Diabetes, and Metabolism, School of Clinical and Experimental Medicine, University of Birmingham, Birmingham, B15 2TT, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1] Oncology Drug Discovery Group, Section of Investigative Medicine, Hammersmith Hospital, Imperial College London, London W12 0NN, UK [2] Centre for Endocrinology, Diabetes, and Metabolism, School of Clinical and Experimental Medicine, University of Birmingham, Birmingham B15 2TT, UK","institution_ids":["https://openalex.org/I2801748203","https://openalex.org/I47508984","https://openalex.org/I79619799"]},{"raw_affiliation_string":"Centre for Endocrinology, Diabetes, and Metabolism, School of Clinical and Experimental Medicine, University of Birmingham, Birmingham, B15 2TT, UK","institution_ids":["https://openalex.org/I79619799"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":6,"corresponding_author_ids":["https://openalex.org/A5082393921"],"corresponding_institution_ids":["https://openalex.org/I2801748203","https://openalex.org/I47508984","https://openalex.org/I79619799"],"apc_list":{"value":5190,"currency":"USD","value_usd":5190},"apc_paid":{"value":5190,"currency":"USD","value_usd":5190},"fwci":0.8191,"has_fulltext":true,"cited_by_count":14,"citation_normalized_percentile":{"value":0.72673821,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"111","issue":"2","first_page":"300","last_page":"308"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":0.8740000128746033,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":0.8740000128746033,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10492","display_name":"Microtubule and mitosis dynamics","score":0.09669999778270721,"subfield":{"id":"https://openalex.org/subfields/1307","display_name":"Cell Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10274","display_name":"Heterocyclic Compound Synthesis and Bioactivity","score":0.011300000362098217,"subfield":{"id":"https://openalex.org/subfields/1605","display_name":"Organic Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/taxane-resistance","display_name":"taxane resistance","score":0.8730000257492065},{"id":"https://openalex.org/keywords/breast-cancer","display_name":"breast cancer","score":0.984000027179718},{"id":"https://openalex.org/keywords/paclitaxel","display_name":"paclitaxel","score":0.7630000114440918},{"id":"https://openalex.org/keywords/microtubule-disrupting-agents","display_name":"microtubule-disrupting agents","score":0.8299999833106995},{"id":"https://openalex.org/keywords/antiangiogenic-activity","display_name":"antiangiogenic activity","score":0.8859999775886536},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.8920000195503235},{"id":"https://openalex.org/keywords/p53","display_name":"p53","score":0.8130000233650208},{"id":"https://openalex.org/keywords/bcl-2-phosphorylation","display_name":"Bcl-2 phosphorylation","score":0.9559999704360962},{"id":"https://openalex.org/keywords/caspase-3","display_name":"caspase-3","score":0.9319999814033508},{"id":"https://openalex.org/keywords/cell-cycle-arrest","display_name":"cell cycle arrest","score":0.8119999766349792},{"id":"https://openalex.org/keywords/oral-bioavailability","display_name":"oral bioavailability","score":0.7440000176429749},{"id":"https://openalex.org/keywords/xenograft-tumor-growth","display_name":"xenograft tumor growth","score":0.7039999961853027},{"id":"https://openalex.org/keywords/mcf-7-cells","display_name":"MCF-7 cells","score":0.675000011920929},{"id":"https://openalex.org/keywords/mda-mb-231-cells","display_name":"MDA-MB-231 cells","score":0.9520000219345093}],"concepts":[{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.8410259485244751},{"id":"https://openalex.org/C2777292972","wikidata":"https://www.wikidata.org/wiki/Q423762","display_name":"Paclitaxel","level":3,"score":0.8157172203063965},{"id":"https://openalex.org/C2777511904","wikidata":"https://www.wikidata.org/wiki/Q425227","display_name":"Taxane","level":4,"score":0.77668297290802},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6837321519851685},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.47448042035102844},{"id":"https://openalex.org/C96232424","wikidata":"https://www.wikidata.org/wiki/Q4118072","display_name":"Cancer cell","level":3,"score":0.4402497410774231},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4013381004333496},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.3912065029144287},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3912062644958496},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.3404502868652344},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.33166176080703735},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.18935662508010864},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.10623326897621155},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000972","descriptor_name":"Antineoplastic Agents, Phytogenic","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D002453","descriptor_name":"Cell Cycle","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007150","descriptor_name":"Immunohistochemistry","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007546","descriptor_name":"Isoquinolines","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D008810","descriptor_name":"Mice, Inbred C57BL","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008819","descriptor_name":"Mice, Nude","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013451","descriptor_name":"Sulfonic Acids","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D017209","descriptor_name":"Apoptosis","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D017239","descriptor_name":"Paclitaxel","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D023041","descriptor_name":"Xenograft Model Antitumor Assays","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D048708","descriptor_name":"Cell Growth Processes","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D061986","descriptor_name":"MCF-7 Cells","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":5,"locations":[{"id":"doi:10.1038/bjc.2014.188","doi":"https://doi.org/10.1038/bjc.2014.188","is_oa":true,"landing_page_url":"https://doi.org/10.1038/bjc.2014.188","pdf_url":"https://www.nature.com/articles/bjc2014188.pdf","source":{"id":"https://openalex.org/S62966998","display_name":"British Journal of Cancer","issn_l":"0007-0920","issn":["0007-0920","1532-1827"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":"cc-by-nc-sa","license_id":"https://openalex.org/licenses/cc-by-nc-sa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Cancer","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:3464994","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4102933","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-sa","license_id":"https://openalex.org/licenses/cc-by-nc-sa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:4102933","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/4102933","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-sa","license_id":"https://openalex.org/licenses/cc-by-nc-sa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Br J Cancer","raw_type":"Text"},{"id":"pmid:24960406","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24960406","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British journal of cancer","raw_type":"Journal Article"},{"id":"pmh:oai:pure.atira.dk:openaire_cris_publications/1282fa4e-43e3-4e74-97ee-42ecdc26ef03","doi":null,"is_oa":true,"landing_page_url":"https://research.birmingham.ac.uk/en/publications/1282fa4e-43e3-4e74-97ee-42ecdc26ef03","pdf_url":null,"source":{"id":"https://openalex.org/S4306402634","display_name":"University of Birmingham Research Portal (University of Birmingham)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I79619799","host_organization_name":"University of Birmingham","host_organization_lineage":["https://openalex.org/I79619799"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-sa","license_id":"https://openalex.org/licenses/cc-by-nc-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Stengel, C, Newman, S P, Day, J M, Chander, S K, Jourdan, F L, Leese, M P, Ferrandis, E, Regis-lydi, S, Potter, B V L, Reed, M J, Purohit, A & Foster, P A 2014, 'In vivo and in vitro properties of STX2484 : a novel non-steroidal anti-cancer compound active in taxane-resistant breast cancer', British Journal of Cancer, vol. 111, no. 2, pp. 300-308. https://doi.org/10.1038/bjc.2014.188","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1038/bjc.2014.188","doi":"https://doi.org/10.1038/bjc.2014.188","is_oa":true,"landing_page_url":"https://doi.org/10.1038/bjc.2014.188","pdf_url":"https://www.nature.com/articles/bjc2014188.pdf","source":{"id":"https://openalex.org/S62966998","display_name":"British Journal of Cancer","issn_l":"0007-0920","issn":["0007-0920","1532-1827"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":"cc-by-nc-sa","license_id":"https://openalex.org/licenses/cc-by-nc-sa","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Cancer","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.98580002784729}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320328455","display_name":"Ipsen","ror":"https://ror.org/00d801g55"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2008377983.pdf","grobid_xml":"https://content.openalex.org/works/W2008377983.grobid-xml"},"referenced_works_count":36,"referenced_works":["https://openalex.org/W151723881","https://openalex.org/W197578431","https://openalex.org/W1502777806","https://openalex.org/W1570441204","https://openalex.org/W1756949381","https://openalex.org/W1966108836","https://openalex.org/W1968324550","https://openalex.org/W1971579914","https://openalex.org/W1981115272","https://openalex.org/W1995667035","https://openalex.org/W1999928529","https://openalex.org/W2013111661","https://openalex.org/W2014636427","https://openalex.org/W2015498137","https://openalex.org/W2016383514","https://openalex.org/W2026322409","https://openalex.org/W2035743945","https://openalex.org/W2042230351","https://openalex.org/W2055344124","https://openalex.org/W2055397209","https://openalex.org/W2070564226","https://openalex.org/W2073513712","https://openalex.org/W2075557130","https://openalex.org/W2075866838","https://openalex.org/W2085993615","https://openalex.org/W2091856435","https://openalex.org/W2095542113","https://openalex.org/W2096797602","https://openalex.org/W2104913415","https://openalex.org/W2115785123","https://openalex.org/W2121946731","https://openalex.org/W2124038924","https://openalex.org/W2161066917","https://openalex.org/W2161128177","https://openalex.org/W2169965478","https://openalex.org/W2184694295"],"related_works":["https://openalex.org/W3153957985","https://openalex.org/W2057422871","https://openalex.org/W1995667035","https://openalex.org/W4378516652","https://openalex.org/W2161066917","https://openalex.org/W1965919622","https://openalex.org/W2784879094","https://openalex.org/W1978291661","https://openalex.org/W2104513105","https://openalex.org/W2019009849"],"abstract_inverted_index":{"BACKGROUND:":[0],"STX2484":[1,33,53,91,96,116,131,154,165,187],"is":[2,97,117,166],"a":[3,72,79,98,118],"novel":[4],"non-steroidal":[5],"compound":[6],"with":[7,147,172,182],"potent":[8,119],"anti-proliferative":[9],"activity.":[10],"These":[11],"studies":[12],"aimed":[13],"to":[14,89,152,191],"identify":[15],"STX2484's":[16],"mechanism":[17],"of":[18,32,144,195],"action,":[19],"in":[20,25,44,46,55,59,69,76,93,122,125,158,173,179,193],"vivo":[21,77,174,180],"efficacy":[22,54,92,155,181,190],"and":[23,34,40,49,75,112,124,177],"activity":[24,66,176],"taxane-resistant":[26],"breast":[27,128],"cancer":[28,129],"models.":[29,163],"METHODS:":[30],"Effects":[31],"paclitaxel":[35,192],"on":[36],"proliferation,":[37],"cell":[38,109],"cycle":[39,110],"apoptosis":[41],"were":[42],"assessed":[43],"vitro":[45,70,123],"drug-resistant":[47,162],"(MCF-7(DOX))":[48],"non-resistant":[50],"cells":[51,61],"(MCF-7(WT)).":[52],"\u03b2III":[56],"tubulin":[57,99],"overexpression":[58],"MCF-7":[60],"was":[62,67,87,156],"also":[63],"determined.":[64],"Anti-angiogenic":[65],"quantified":[68],"by":[71,139],"co-culture":[73],"model":[74,86],"using":[78],"Matrigel":[80],"plug":[81],"assay.":[82],"An":[83],"MDA-MB-231":[84],"xenograft":[85],"used":[88],"determine":[90],"vivo.":[94,126],"RESULTS:":[95],"disruptor,":[100],"which":[101],"induces":[102],"p53":[103],"expression,":[104],"Bcl2":[105],"phosphorylation,":[106],"caspase-3":[107],"cleavage,":[108],"arrest":[111],"apoptosis.":[113],"In":[114,127,150],"addition,":[115],"anti-angiogenic":[120,175],"agent":[121,171],"xenografts,":[130],"(20":[132],"mg":[133],"kg(-1)":[134],"p.o.)":[135],"suppressed":[136],"tumour":[137],"growth":[138],"84%":[140],"after":[141],"35":[142],"days":[143],"daily":[145],"dosing,":[146],"limited":[148],"toxicity.":[149,185],"contrast":[151],"paclitaxel,":[153],"unchanged":[157],"two":[159],"clinically":[160],"relevant":[161],"CONCLUSIONS:":[164],"an":[167],"orally":[168],"bioavailable":[169],"microtubule-disrupting":[170],"excellent":[178],"no":[183],"apparent":[184],"Crucially,":[186],"has":[188],"superior":[189],"models":[194],"clinical":[196],"drug":[197],"resistance.":[198]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":3},{"year":2017,"cited_by_count":1},{"year":2015,"cited_by_count":3},{"year":2013,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}